arrow_back Back Filing freshness 10-Q Q2 FY2027 SEC EDGAR

NutriBand Inc.

NTRB
$5.52 ▼ -0.56 (-9.21%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
43 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
9
Health
Poor
Bearish
auto_awesome

Analytical Summary

NutriBand Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $67.1M
Dividend Yield —
Revenue Growth -29.7% ↗
Op. Margin -203.6% ↗
ROIC -13.2% ↗
FCF / Share $-0.05 ↘
Trailing P/E —
Price / Book 12.6x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

43-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$437.51K
↓ -29.7% —
Net Income Profit after all expenses
$-880.56K
↑ +56.0% —
Operating Margin Operating profit as % of sales
-203.6%
↑ +29.7% 0th
FCF / Share Free cash flow per share
$-0.05
↓ -3.9% —
Long-Term Debt Long-term obligations
$1.70K
↓ -1.4% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability →
0
Returns ↓
6
Financial Health ↓
9
Cash Quality ↑
44

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 11 years · 43 quarters